Josep Rodés-Cabau
Latest contributions
Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis and small aortic annuli: A randomized clinical trial (the VIVA Trial)
27 Oct 2023
Luis Ortega-Paz interviews Josep Rodés-Cabau on the results of the VIVA trial which he presented at TCT Congress 2023 in San Francisco.
Author
Author
TAVI patients’ Lifetime Management: the unspoken consequences of Permanent Pacemaker Implantation
31 Oct 2022
Watch the replay of this webinar on TAVI with J. Rodés-Cabau, F. Saia and M. Ziacchi
Interventions for hypertension and heart failure
19 May 2022 – From EuroPCR 2022
View slides and videos on procedures for hypertension and heart failure including observations and outcomes from the RELIEVE-HF roll-in cohort, a novel approach for performing renal denervation, RDN registry of a resistant hypertension multidisciplinary team..
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...
